- 7 days & nights inpatient stay
- 1 quick follow-up appointment
This clinical trial has been approved by an independent ethics committee.
About the study
This study is looking at a medication for the treatment for Idiopathic Pulmonary fibrosis which is a chronic disease in which lung tissue becomes thickened and scarred, leading to increased difficulty in breathing and decreased quality of life.
The medication’s purpose is to prevent the growth of fibrotic tissue within the lung and bile ducts. This medication is also being tested in Phase 2 trials in patients with the condition.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Breathe Easy Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!